Taxpayers fund research labs, private firms harvest the profits
S. 3468 — National Programmable Cloud Laboratories Network Act of 2025 · Filed by John Fetterman (D-PA) · 1 cosponsor · Introduced Dec 11, 2025 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a federally funded network of up to 6 'programmable cloud laboratories'—physical labs equipped with robots, AI, and remote-control capabilities—to conduct automated research. The National Science Foundation will award up to $5 million per year per lab for 5 years (totaling $30 million annually through 2030). Labs must be at universities, nonprofits, or private companies, and must demonstrate a path to financial self-sufficiency and private cost-sharing. The bill aims to reduce research costs, accelerate commercialization of government-funded discoveries, and maintain U.S. competitiveness in automation and biotech.
Why we flagged it
The bill establishes federally funded research labs but explicitly prioritizes private-sector commercialization of government-funded discoveries and requires private cost-sharing. It is a subsidy to research infrastructure with built-in mechanisms to transfer public investment to private profit.
What the text implies
- The bill requires nodes to develop 'financial sustainability plans' and 'revenue-generating models' (user fees, licensing, consortia membership), meaning public infrastructure may eventually be operated as a fee-for-service platform accessible primarily to well-funded private firms and wealthy institutions.
- Section 3(3) explicitly states a purpose is 'to accelerate national competitiveness by transferring government-funded research to private-sector commercial applications'—this is a direct subsidy to private commercialization of taxpayer-funded discoveries with no requirement to share profits or license terms with the public.
The full analysis lists 5 implications of this text.
Who stands to gain
private sector research entities; biotechnology and advanced manufacturing companies; AI and robotics vendors (hardware/software suppliers)